Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis

PURPOSE: Although inhibitors of vascular endothelial growth factor and inhibitors of epidermal growth factor receptor (EGFRi) are commonly used for the treatment of metastatic colorectal cancer (mCRC), the optimal sequencing of these agents is currently unclear. METHODS: A national registry of targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchler, Tomas, Chloupkova, Renata, Poprach, Alexandr, Fiala, Ondrej, Kiss, Igor, Kopeckova, Katerina, Dusek, Ladislav, Veskrnova, Veronika, Slavicek, Lubomir, Kohoutek, Milan, Finek, Jindrich, Svoboda, Marek, Petruzelka, Lubos, Melichar, Bohuslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314050/
https://www.ncbi.nlm.nih.gov/pubmed/30643461
http://dx.doi.org/10.2147/CMAR.S183093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314050/
https://www.ncbi.nlm.nih.gov/pubmed/30643461
http://dx.doi.org/10.2147/CMAR.S183093

Ejemplares similares